November 2018 True Leaf Medicine International Ltd

November 2018

True Leaf Medicine International Ltd.

CanadaUnited States

Germany

CS: MJOTCQB: TRLFFFSE: TLA

DISCLAIMERForward Looking Statements

This Presentation (the “Presentation”) has been prepared solely for informational purposes by True Leaf Medicine International Ltd. (“True Leaf) and is solely for use byprospective investors and other third parties in connection with their consideration of an investment in True Leaf. This presentation is not, and should not be assumed tobe, complete. This presentation has been prepared to assist interested parties in making their own evaluation of True Leaf and does not purport to contain all of theinformation that may be relevant. In all cases, interested parties should conduct their own investigation and analysis of True Leaf and the data set forth in thispresentation and other information provided by or on behalf of True Leaf. Any views and opinions expressed in this presentation are those of True Leaf and do notnecessarily represent facts. In addition, certain of the information contained herein may be derived from information provided by industry sources. True Leaf believes thatsuch information is accurate and that the sources from which it has been obtained are reliable. True Leaf cannot guarantee the accuracy of such information, however,and has not independently verified such information. The information presented herein remains subject to change. Statements in this presentation are made as of thedate of this presentation unless stated otherwise.

This presentation also contains statements that, to the extent they are not recitations of historical fact, constitute “forward-looking statements.” Forward-lookingstatements are typically identified by the use of terms such as “may,” “should,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,”“predict,” “potential” or the negative of such terms and other comparable terminology. The forward-looking statements included herein are based upon True Leaf’scurrent expectations, plans, estimates, assumptions and beliefs that involve numerous risks and uncertainties. Assumptions relating to the foregoing involve judgmentswith respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predictaccurately and many of which are beyond True Leaf’ control. Although True Leaf believes that the expectations reflected in such forward-looking statements are based onreasonable assumptions, True Leaf’ actual results and performance and the value of its securities could differ materially from those set forth in the forward-lookingstatements due to the impact of many factors including, but not limited to, risks and uncertainties detailed in the “Risk Factors” in the Risk Factors section of True Leaf’Offering Circular on Form 1-A, filed with the U.S. Securities and Exchange Commission and other discussions of risk factors contained in True Leaf’s periodic filings orsupplements to the offering circular. True Leaf Offering Circular on Form 1-A can be found at https://www.trueleaf.com/pages/investor. True Leaf claims the safe harborprotection for forward looking statements contained in the Private Securities Litigation Reform Act of 1995. True Leaf undertakes no obligation to update or revise anysuch information for any reason after the date of this presentation, unless required by law.

Investment in True Leaf’s securities involves significant risks. You should purchase these securities only if you can afford a complete loss of your investment.

True LeafOverview | Pet | Financials 2www.trueleaf.com |

RETURN THE LOVE

Our PurposeTo help pets live healthier lives by embracing natural alternatives

Our VisionGlobal cannabis-for-pets brand leader

True LeafOverview | Pet | Financials www.trueleaf.com | 3

UNDERSTANDING CANNABIS USESDifferentiation of hemp, hempseed, CBD-producing flowers, and more

<0.3% THCis the requirement for a

cannabis plant to be defined as hemp

Marijuana

Cannabis

Hemp

Hemp w/ CBD

• Contains cannabinoids (THC, CBD, e.g.)

• Illegal in most jurisdictions• Medicinal and psychoactive

properties

Hemp w/ trace levels of

CBD


CANNABIS IN THE MARKET


Hemp Seed CBD

TRUE LEAF COMMERCIAL STRATEGYPremiere Branding is a Key Differentiator

Dossier is our design and innovation partner that brings a solid track record and process to creating and scaling consumer centered brand platforms.

Creating Brand Insistence

1

2

34

5

The 5 Consumer Drivers

Emotional Engaging

ValueDrivers

AccessibilityAwareness

RelevantDifferentiation


Global brand recognition with our legal products will drive growth and

set True Leaf apart from its peers in both the pets and cannabis space

TRUE LEAF VISIONGlobal cannabis-for-pets brand leader

PET

$184.1

billionCAGR: 4.9%

CANNABIS

$93.8 billionCAGR: 24.9%

True Leaf serves two of the

hottest industries worldwide

References1. Grandview Market Research Estimates. Estimates are for 2023, calculated from 2025 figures.2. Pet Care Global Industry Overview. Euromonitor.


TRUE LEAF MARKET OPPORTUNITYLarge Obtainable Market Opportunity in Pets and Cannabis

$300 millionServiceable Obtainable Market

1.01 % of TAM

$29.6 billionServiceable Available Market (Global

pet products markets)

$184.1 billionTotal Available Market

Global Pet Care Market

2023

$31 millionServiceable Obtainable Market

0.03% of TAM

$5.5 billionServiceable Available Market (Canada)

$93.8 billionTotal Available Market

Global Legal Cannabis Market

2023


Growth plans support $300

million to $350 million of

revenue over the next 5 years

True LeafOverview | Pet | Financials

Market Outlook

Market Positioning

• Pioneer of ‘hemp-based’ product in North America and Europe

• Legal hemp-based products with no CBD/THC in US

• Sold in 2000 stores in North America and Europe

• Carried by leading pet retailers worldwide

Own the Hearts and Minds of Pet OwnersTRUE LEAF PET

www.trueleaf.com | 9

$184 BillionWorldwide Market

$30 BillionUS Pet Food Market

$6 BillionUS Pet Treat Market

Growth• Sales of C$1.4M for fiscal year ended Mar. 31,

2018• 280% increase YoY• Record revenue quarter of C$491 K for Q1 2019

(April to June 2018)• 45% gross margin• 14 dedicated staff in Canada, US and Europe• Exploring acquisition opportunities

International Distribution• Sales in Canada, US, Europe and New Zealand• 2,000 stores across North America, Europe and

New Zealand• Ongoing partnership discussions for Asia

(China, South Korea, Japan, India)

Own the Hearts and Minds of Pet OwnersTRUE LEAF PET

2nd largest pet store in the UK

4th largest pet store in North America2nd largest pet store in

Germany

True LeafOverview | Pet | Financials

Canada

www.trueleaf.com | 10

Part of largest pet store in North America

10th largest pet store in North America



OUR CUSTOMERSTarget demographics

75.4 MILLION MILLENNIALS

35% have a dog or catPets instead of having kidsCannabis over alcohol

74.9 MILLION BABY BOOMERS

32% own petsEmpty nestersCannabis over pharma


PET GROWTH STRATEGYTraditional Distribution / Direct-to-Store / Direct-to-Consumer

North America

Europe

Asia Pacific

> Traditional Distribution> Direct-to-Store> Direct-to-Consumer

> Traditional Distribution

> Direct-to-Store

> Direct-to-Consumer

2000Currently in

Stores


> Traditional Distribution

> Direct-to-Store

TRUE LEAF CAMPUS

Overview• 40-acre site in Lumby, BC, Okanagan’s agricultural region

• Groundbreaking March 2, 2018

• Central 18,000 sq. ft. hub, hydroponic grow, future fractionation,

purification and laboratory facilities

• Completion for Fall 2018

Licensing Timeline• License to Grow – Spring 2019*

• License to Sell – Fall 2019*

‣ Phase 1 capacity – 1,500 kgs/yr

‣ Phase 2 capacity – 10,000 kgs/yr

*Subject to Health Canada approval


2018 KEY MILESTONESCorporate Overview

January to March

✓Raised $14 MM CAD via SEC compliant Reg A+ equity crowdfunding

✓Purchased 40-acres in Lumby, BC

✓Retained Dossier

April to June

✓ Announced cultivation team

✓Broke ground on Phase 1 of True Leaf Campus

✓280% revenue growth FY 2018 (YE Mar 31)

July to Sep

✓Recruited Sylvain Toutant, former David’s Tea CEO, to Board

✓Launched Veterinarian Advisory Board with Founding Chair Dr. Katherine Kramer

✓Appointed CFO Kerry Biggs, formerly of Lululemon

✓Record revenue quarter Q1 2019 (Apr – Jun 2018)

2H 2018

□ Complete TL Campus construction

□ Select capital markets advisory partner

□ Close next financing round

□ Up-list to major exchange(s)

□ Line extensions

1H 2019

□ Receive License to Grow and Sell

□ Launch global rebrand campaign

□ Launch new hemp-seed and CBD/THC product lines


COMPANY COMPARISONSCannabis, Pet, Health & Wellness Valuation

True LeafOverview | Pet | Med | Financials www.trueleaf.com | 15

HEA

LTH

& W

ELLN

ESS

/ P

ET

Acquisition Date COMPANY DESCRIPTION SALES ACQUISITION PRICE SALES MUTIPLE

June 2015 Vega®(2015) Plant-based Protein Foods $135 M C$715 M 5.3 X

June 2015 Manitoba Harvest(2015) Hemp-based Foods $38M C$133M 3.5 X

Pet Products

May 2018 Ainsworth Pet (2018) Rachel Ray® $1.9B USD -

April 2018 Blue Buffalo®(2018) Pet Food $1.3B USD $8 B USD 6.25 X

March 2015 Wag® (2017) Dog Walking App $300M investment $650M valuation -

January 2018 Big Heart Brands®(2015)Meow Mix®, Milk-Bone®

Natural Balance® $2.23B $5.8 B USD 2.6X

January 2014 Zukes® (2014) Pet Treat brand $25M* $75M* 3X

CA

NN

AB

IS

COMPANY STOCK SYMBOLLAST PRICE(SEPT 9/17)

Oct 31, 2018 MARKET CAP YEAR END REVENUES

Canopy Growth NYSE: CHC $9.18 $48.29 CAD $11.30 B CAD $55.14 M CAD

Tilray Nasdaq: TLRY - $124.08 CAD $11.82 B CAD $10.1 M CAD

Aurora Cannabis NYSE: ACB $2.23 $8.90 CAD $8.68 B CAD $18.07 M CAD

Aphria APH.TO $6.01 $15.70 CAD $3.83 B CAD $20.44 M CAD

Cronos Group CRON.TO - $9.72 CAD $1.76 B CAD $4.1 M CAD

Green Organic Dutchman (TGOD) TGOD.CN - $3.10 CAD $779 M CAD Non-revenue generating

HIKU Brands HIKU.CN - $2.76 CAD $464 M CAD Non-revenue generating

Terrascend TER.CN - $9.24 CAD $886 M CAD Non-revenue generating

Supreme Cannabis FIRE.V - $1.56 CAD $440 M CAD Non-revenue generating

True Leaf MJ $0.51 $0.51 CAD $49.03 M CAD $1.4 M CAD

LEADERSHIPExpertise in pets, cannabis, retail, branding and government

Executive– Darcy Bomford, Founder and CEO

– Tenzin Khangsar, Executive VP

– Kerry Biggs, CPA, MBA – Chief Financial Officer

– Don Chisholm , VP Global Branding

– Steve Schroeder, Chief Cannabis Industry Advisor

Board of Directors– Mike Harcourt, OC. Chair

– Darcy Bomford

– Sylvain Toutant, CEO of DAVIDsTEA

– Kevin Bottomley

Veterinary Advisory Board– Dr. Katherine Kramer, DVM

Advisors– Osler, Hoskin & Harcourt LLP

– Edison Group

– Dossier Creative

– Hill + Knowlton Strategies

– BreakThrough CommunIcations


CORPORATE SUMMARYWhat makes us special?

✓ True Leaf: global cannabis-for-pets brand

✓ Pioneer of hemp seed-based pet products

✓ High-growth industries: Pet and Cannabis

✓ Legal revenue in 2000+ stores worldwide

✓ First cannabis company with successful SEC-compliant financing


Documents

November 2018 True Leaf Medicine International Ltd